Related Experiment Videos
[NF-kappa B and inflammatory intestinal diseases]
M P Nosti-Escanilla1, A S Peña
1Departamento de Gastroenterología, Universidad Libre de Amsterdam, Países Bajos.
Revista Espanola De Enfermedades Digestivas
|May 15, 1998
Summary
Genetic factors influence inflammatory bowel diseases (IBD). Nuclear factor kappa B (NF kappa B) is key in regulating inflammation and IBD, with new therapies targeting its pathway.
Area of Science:
- Immunology
- Genetics
- Gastroenterology
Context:
- Chronic inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are complex multifactorial conditions.
- Genetic predisposition significantly contributes to the development of IBD.
- The intensity of the inflammatory response in IBD is influenced by genes controlling cytokine production.
Purpose:
- To elucidate the structure, function, regulation, and role of Nuclear Factor kappa B (NF kappa B) in IBD.
- To review mechanisms of glucocorticosteroid action related to NF kappa B.
- To explore novel therapeutic strategies for IBD targeting the NF kappa B pathway.
Summary:
- NF kappa B is identified as a critical regulator of pro- and anti-inflammatory gene expression.
- The review details NF kappa B's physiological mechanisms and its involvement in IBD pathogenesis.
- Emerging therapies include adenoviral transfer of mutant I kappa B and local p65 antisense oligonucleotides.
Impact:
- Enhanced understanding of NF kappa B physiology provides insights into IBD.
- New therapeutic avenues for inflammatory diseases are emerging based on NF kappa B modulation.
- Targeting NF kappa B offers potential for more effective IBD treatments.